TY - JOUR
T1 - CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis
AU - Dobson-Stone, Carol
AU - Hallupp, Marianne
AU - Shahheydari, Hamideh
AU - Ragagnin, Audrey M. G.
AU - Chatterton, Zac
AU - Carew-Jones, Francine
AU - Shepherd, Claire E.
AU - Stefen, Holly
AU - Paric, Esmeralda
AU - Fath, Thomas
AU - Thompson, Elizabeth M.
AU - Blumbergs, Peter
AU - Short, Cathy L.
AU - Field, Colin D.
AU - Panegyres, Peter K.
AU - Hecker, Jane
AU - Nicholson, Garth
AU - Shaw, Alex D.
AU - Fullerton, Janice M.
AU - Luty, Agnes A.
AU - Schofield, Peter R.
AU - Brooks, William S.
AU - Rajan, Neil
AU - Bennett, Mark F.
AU - Bahlo, Melanie
AU - Shankaracharya,
AU - Landers, John E.
AU - Piguet, Olivier
AU - Hodges, John R.
AU - Halliday, Glenda M.
AU - Topp, Simon D.
AU - Smith, Bradley N.
AU - Shaw, Christopher E.
AU - McCann, Emily
AU - Fifita, Jennifer A.
AU - Williams, Kelly L.
AU - Atkin, Julie D.
AU - Blair, Ian P.
AU - Kwok, John B.
PY - 2020/3/1
Y1 - 2020/3/1
N2 - Frontotemporal dementia and amyotrophic lateral sclerosis are clinically and pathologically overlapping disorders with shared genetic causes. We previously identified a disease locus on chromosome 16p12.1-q12.2 with genome-wide significant linkage in a large European Australian family with autosomal dominant inheritance of frontotemporal dementia and amyotrophic lateral sclerosis and no mutation in known amyotrophic lateral sclerosis or dementia genes. Here we demonstrate the segregation of a novel missense variant in CYLD (c.2155A>G, p.M719V) within the linkage region as the genetic cause of disease in this family. Immunohistochemical analysis of brain tissue from two CYLD p.M719V mutation carriers showed widespread glial CYLD immunoreactivity. Primary mouse neurons transfected with CYLDM719V exhibited increased cytoplasmic localization of TDP-43 and shortened axons. CYLD encodes a lysine 63 deubiquitinase and CYLD cutaneous syndrome, a skin tumour disorder, is caused by mutations that lead to reduced deubiquitinase activity. In contrast with CYLD cutaneous syndrome-causative mutations, CYLDM719V exhibited significantly increased lysine 63 deubiquitinase activity relative to the wild-type enzyme (paired Wilcoxon signed-rank test P = 0.005). Overexpression of CYLDM719V in HEK293 cells led to more potent inhibition of the cell signalling molecule NF-κB and impairment of autophagosome fusion to lysosomes, a key process in autophagy. Although CYLD mutations appear to be rare, CYLD's interaction with at least three other proteins encoded by frontotemporal dementia and/or amyotrophic lateral sclerosis genes (TBK1, OPTN and SQSTM1) suggests that it may play a central role in the pathogenesis of these disorders. Mutations in several frontotemporal dementia and amyotrophic lateral sclerosis genes, including TBK1, OPTN and SQSTM1, result in a loss of autophagy function. We show here that increased CYLD activity also reduces autophagy function, highlighting the importance of autophagy regulation in the pathogenesis of frontotemporal dementia and amyotrophic lateral sclerosis.
AB - Frontotemporal dementia and amyotrophic lateral sclerosis are clinically and pathologically overlapping disorders with shared genetic causes. We previously identified a disease locus on chromosome 16p12.1-q12.2 with genome-wide significant linkage in a large European Australian family with autosomal dominant inheritance of frontotemporal dementia and amyotrophic lateral sclerosis and no mutation in known amyotrophic lateral sclerosis or dementia genes. Here we demonstrate the segregation of a novel missense variant in CYLD (c.2155A>G, p.M719V) within the linkage region as the genetic cause of disease in this family. Immunohistochemical analysis of brain tissue from two CYLD p.M719V mutation carriers showed widespread glial CYLD immunoreactivity. Primary mouse neurons transfected with CYLDM719V exhibited increased cytoplasmic localization of TDP-43 and shortened axons. CYLD encodes a lysine 63 deubiquitinase and CYLD cutaneous syndrome, a skin tumour disorder, is caused by mutations that lead to reduced deubiquitinase activity. In contrast with CYLD cutaneous syndrome-causative mutations, CYLDM719V exhibited significantly increased lysine 63 deubiquitinase activity relative to the wild-type enzyme (paired Wilcoxon signed-rank test P = 0.005). Overexpression of CYLDM719V in HEK293 cells led to more potent inhibition of the cell signalling molecule NF-κB and impairment of autophagosome fusion to lysosomes, a key process in autophagy. Although CYLD mutations appear to be rare, CYLD's interaction with at least three other proteins encoded by frontotemporal dementia and/or amyotrophic lateral sclerosis genes (TBK1, OPTN and SQSTM1) suggests that it may play a central role in the pathogenesis of these disorders. Mutations in several frontotemporal dementia and amyotrophic lateral sclerosis genes, including TBK1, OPTN and SQSTM1, result in a loss of autophagy function. We show here that increased CYLD activity also reduces autophagy function, highlighting the importance of autophagy regulation in the pathogenesis of frontotemporal dementia and amyotrophic lateral sclerosis.
KW - autophagy
KW - CYLD
KW - deubiquitinase
KW - genome-wide linkage analysis
KW - whole-exome sequencing
UR - http://www.scopus.com/inward/record.url?scp=85082342425&partnerID=8YFLogxK
UR - http://purl.org/au-research/grants/nhmrc/1062539
UR - http://purl.org/au-research/grants/nhmrc/1140708
UR - http://purl.org/au-research/grants/nhmrc/1083209
UR - http://purl.org/au-research/grants/nhmrc/1095215
UR - http://purl.org/au-research/grants/nhmrc/1037746
UR - http://purl.org/au-research/grants/nhmrc/1095127
UR - http://purl.org/au-research/grants/nhmrc/1132524
UR - http://purl.org/au-research/grants/nhmrc/1138223
UR - http://purl.org/au-research/grants/arc/DP180101473
UR - http://purl.org/au-research/grants/nhmrc/1063960
UR - http://purl.org/au-research/grants/nhmrc/1054618
UR - http://purl.org/au-research/grants/nhmrc/1103258
UR - http://purl.org/au-research/grants/nhmrc/1079679
U2 - 10.1093/brain/awaa039
DO - 10.1093/brain/awaa039
M3 - Article
C2 - 32185393
SN - 0006-8950
VL - 143
SP - 783
EP - 799
JO - Brain : a journal of neurology
JF - Brain : a journal of neurology
IS - 3
ER -